SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Everest Organics - Quaterly Results

13 Aug 2024 Evaluate
The sales slipped to Rs. 324.46 millions for the June 2024 quarter as against Rs. 426.70 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -60.89 millions as compared to Net Profit of Rs. 0.34 millions of corresponding quarter ended June 2023Operating profit Margin for the quarter ended June 2024 slipped to -33.32% as compared to 27.41% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 324.46 426.70 -23.96 324.46 426.70 -23.96 1972.41 1830.48 7.75
Other Income 3.25 2.20 47.73 3.25 2.20 47.73 8.86 69.44 -87.24
PBIDT -33.32 27.41 -221.56 -33.32 27.41 -221.56 118.72 78.73 50.79
Interest 12.88 12.89 -0.08 12.88 12.89 -0.08 54.66 33.10 65.14
PBDT -46.20 14.52 -418.18 -46.20 14.52 -418.18 64.06 45.63 40.39
Depreciation 14.68 12.94 13.45 14.68 12.94 13.45 57.95 44.74 29.53
PBT -60.88 1.58 -3953.16 -60.88 1.58 -3953.16 6.11 0.89 586.52
TAX 0.01 1.24 -99.19 0.01 1.24 -99.19 4.71 2.72 73.16
Deferred Tax 0.01 0.84 -98.81 0.01 0.84 -98.81 3.71 2.57 44.36
PAT -60.89 0.34 -18008.82 -60.89 0.34 -18008.82 1.40 -1.83 -176.50
Equity 80.00 80.00 0.00 80.00 80.00 0.00 80.00 80.00 0.00
PBIDTM(%) -10.27 6.42 -259.87 -10.27 6.42 -259.87 6.02 4.30 39.94

Everest Organics Share Price

267.75 17.65 (7.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×